首页 > 最新文献

Advances in medical sciences最新文献

英文 中文
Pooled granulocyte component-a worthy rival to the apheresis product? 汇集的粒细胞成分-一个有价值的竞争对手的分离产品?
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-24 DOI: 10.1016/j.advms.2026.01.002
Artur Szumowski, Tomasz Wasiluk, Magdalena Średzińska, Kamila Rybińska, Mateusz Dziemiańczuk, Paulina Radziwon, Michał Kuźma, Piotr Radziwon

Purpose: Granulocyte concentrates (GCs) are crucial in preventing and treating hazardous infections in neutropenic patients with hematological malignancies. Our study goal was to evaluate the impact of various collection and preparation methods on the quality of GCs.

Materials and methods: Our study included 30 GCs that were collected either by leukapheresis (group L), by standard buffy coat pooling (group S), or by using the Reveos system (group R). All studied GCs were irradiated with gamma rays and stored for 24 h at room temperature without agitation. Laboratory tests included the assessment of leukocyte (WBC), neutrophil, lymphocyte and monocyte counts, pH, cell viability, phagocytosis, and the expression of CD11b, CD62L, CD66b and CXCR4 molecules.

Results: We showed that GCs prepared using different methods differed primarily in terms of cell counts, cell viability, and the CD11b, CD62L and CXCR4 expression. We also observed that gamma irradiation expectedly reduced the lymphocyte count, whereas 24-h storage drastically reduced cell viability. An additional effect of the preparation method on GCs susceptibility to quality changes due to gamma rays and 24-h storage was noticed as well.

Conclusions: Our research indicates that apheresis-derived granulocytes and pooled GCs do not differ enough to not consider more frequent use of the latter in daily clinical practice. Moreover, we concluded that gamma irradiation does not worsen the quality of granulocyte components, and freshly collected GCs should be preferred.

目的:粒细胞浓缩物(GCs)在预防和治疗中性粒细胞减少合并血液系统恶性肿瘤患者的危险感染中起着至关重要的作用。我们的研究目的是评价不同的收集和制备方法对gc质量的影响。材料和方法:我们的研究包括30个gc,分别通过白细胞分离(L组)、标准黄皮池(S组)和revos系统(R组)收集。所有研究的gc都用伽马射线照射,并在室温下不搅拌保存24小时。实验室检测包括白细胞(WBC)、中性粒细胞、淋巴细胞和单核细胞计数、pH、细胞活力、吞噬能力以及CD11b、CD62L、CD66b和CXCR4分子的表达。结果:我们发现,不同方法制备的gc主要在细胞计数、细胞活力以及CD11b、CD62L和CXCR4表达方面存在差异。我们还观察到伽马辐射预期会减少淋巴细胞计数,而24小时储存则会大大降低细胞活力。另外还注意到制备方法对伽马射线和隔夜储存引起的gc对质量变化的敏感性的影响。结论:我们的研究表明,分离来源的粒细胞和合并的GCs之间的差异并不大,不需要考虑在日常临床实践中更频繁地使用后者。此外,我们得出结论,伽马辐照不会使粒细胞成分的质量恶化,应优先使用新鲜收集的gc。
{"title":"Pooled granulocyte component-a worthy rival to the apheresis product?","authors":"Artur Szumowski, Tomasz Wasiluk, Magdalena Średzińska, Kamila Rybińska, Mateusz Dziemiańczuk, Paulina Radziwon, Michał Kuźma, Piotr Radziwon","doi":"10.1016/j.advms.2026.01.002","DOIUrl":"10.1016/j.advms.2026.01.002","url":null,"abstract":"<p><strong>Purpose: </strong>Granulocyte concentrates (GCs) are crucial in preventing and treating hazardous infections in neutropenic patients with hematological malignancies. Our study goal was to evaluate the impact of various collection and preparation methods on the quality of GCs.</p><p><strong>Materials and methods: </strong>Our study included 30 GCs that were collected either by leukapheresis (group L), by standard buffy coat pooling (group S), or by using the Reveos system (group R). All studied GCs were irradiated with gamma rays and stored for 24 h at room temperature without agitation. Laboratory tests included the assessment of leukocyte (WBC), neutrophil, lymphocyte and monocyte counts, pH, cell viability, phagocytosis, and the expression of CD11b, CD62L, CD66b and CXCR4 molecules.</p><p><strong>Results: </strong>We showed that GCs prepared using different methods differed primarily in terms of cell counts, cell viability, and the CD11b, CD62L and CXCR4 expression. We also observed that gamma irradiation expectedly reduced the lymphocyte count, whereas 24-h storage drastically reduced cell viability. An additional effect of the preparation method on GCs susceptibility to quality changes due to gamma rays and 24-h storage was noticed as well.</p><p><strong>Conclusions: </strong>Our research indicates that apheresis-derived granulocytes and pooled GCs do not differ enough to not consider more frequent use of the latter in daily clinical practice. Moreover, we concluded that gamma irradiation does not worsen the quality of granulocyte components, and freshly collected GCs should be preferred.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"27-39"},"PeriodicalIF":2.6,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prothrombotic potential of diabetic patients with ischemic heart failure is associated with impaired left ventricular contractility and endothelial dysfunction. 糖尿病合并缺血性心力衰竭患者的血栓前电位与左心室收缩功能受损和内皮功能障碍有关。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-23 DOI: 10.1016/j.advms.2026.01.003
Karol Witold Nowak, Aleksander Siniarski, Alicia Del Carmen Yika, Aleksandra Karcinska, Anna Matrejek, Konrad Stepien, Jadwiga Nessler, Grzegorz Gajos, Jaroslaw Zalewski

Purpose: We sought to investigate whether left ventricular (LV) contractility and endothelial dysfunction in diabetic patients with ischemic heart failure (HF) are associated with enhanced thrombin generation and altered fibrin clot properties compared with individuals without HF.

Materials and methods: The study included 85 HF patients with type 2 diabetes (T2DM) and ischemic heart disease (IHD). Based on echocardiographic examination, 39 (45.9 %) patients were identified as having LV ejection fraction (LVEF) of <40 % (HFrEF) while 46 patients (54.1 %) of ≥50 % (HFpEF). The control group (n = 43) consisted of diabetic and IHD participants without HF (non-HF). In all groups, endogenous thrombin potential (ETP), fibrin clot permeability (Ks), brachial artery flow-mediated dilation (FMD), and nitroglycerin-mediated dilatation (NMD) were assessed.

Results: HFrEF and HFpEF patients had less permeable fibrin clots than non-HF by 45.4 % and by 14.6 %, respectively (P < 0.05 both). HFrEF patients had higher ETP by 14.4 % (P = 0.004), lower Ks by 16.9 % (P = 0.037) and lower NMD by 34.7 % (P = 0.001) without differences in FMD as compared with HFpEF. Multivariable analysis adjusted for fibrinogen levels showed that lower LVEF (β-coefficient -0.195, 95 % confidence interval [CI] for β-coefficient -0.385 to -0.015), reduced NMD (β-coefficient -0.230, 95 %CI -0.399 to -0.061), and increased total cholesterol level (β-coefficient 0.286, 95 %CI 0.108-0.464) influenced enhanced ETP in HF population.

Conclusions: In diabetic patients with IHD, the diagnosis of HF is associated with more dense fibrin clots. HF patients with reduced versus preserved LVEF have shown enhanced thrombin generation and reduced clot permeability. Impairment of both LV systolic and vascular vasodilator function affected thrombin generation.

目的:我们试图研究糖尿病合并缺血性心力衰竭(HF)患者与非HF患者相比,左心室(LV)收缩力和内皮功能障碍是否与凝血酶生成增强和纤维蛋白凝块特性改变有关。材料与方法:本研究纳入85例合并2型糖尿病(T2DM)和缺血性心脏病(IHD)的HF患者。基于超声心动图检查,39例(45.9%)患者被确定为左室射血分数(LVEF)。结果:HFrEF和HFpEF患者的渗透性纤维蛋白凝块比非HF患者分别低45.4%和14.6% (p结论:糖尿病合并IHD患者,HF的诊断与更密集的纤维蛋白凝块相关。LVEF减少与保留的HF患者表现出凝血酶生成增强和凝块通透性降低。左室收缩功能和血管舒张功能的损害均影响凝血酶的产生。
{"title":"The prothrombotic potential of diabetic patients with ischemic heart failure is associated with impaired left ventricular contractility and endothelial dysfunction.","authors":"Karol Witold Nowak, Aleksander Siniarski, Alicia Del Carmen Yika, Aleksandra Karcinska, Anna Matrejek, Konrad Stepien, Jadwiga Nessler, Grzegorz Gajos, Jaroslaw Zalewski","doi":"10.1016/j.advms.2026.01.003","DOIUrl":"10.1016/j.advms.2026.01.003","url":null,"abstract":"<p><strong>Purpose: </strong>We sought to investigate whether left ventricular (LV) contractility and endothelial dysfunction in diabetic patients with ischemic heart failure (HF) are associated with enhanced thrombin generation and altered fibrin clot properties compared with individuals without HF.</p><p><strong>Materials and methods: </strong>The study included 85 HF patients with type 2 diabetes (T2DM) and ischemic heart disease (IHD). Based on echocardiographic examination, 39 (45.9 %) patients were identified as having LV ejection fraction (LVEF) of <40 % (HFrEF) while 46 patients (54.1 %) of ≥50 % (HFpEF). The control group (n = 43) consisted of diabetic and IHD participants without HF (non-HF). In all groups, endogenous thrombin potential (ETP), fibrin clot permeability (Ks), brachial artery flow-mediated dilation (FMD), and nitroglycerin-mediated dilatation (NMD) were assessed.</p><p><strong>Results: </strong>HFrEF and HFpEF patients had less permeable fibrin clots than non-HF by 45.4 % and by 14.6 %, respectively (P < 0.05 both). HFrEF patients had higher ETP by 14.4 % (P = 0.004), lower Ks by 16.9 % (P = 0.037) and lower NMD by 34.7 % (P = 0.001) without differences in FMD as compared with HFpEF. Multivariable analysis adjusted for fibrinogen levels showed that lower LVEF (β-coefficient -0.195, 95 % confidence interval [CI] for β-coefficient -0.385 to -0.015), reduced NMD (β-coefficient -0.230, 95 %CI -0.399 to -0.061), and increased total cholesterol level (β-coefficient 0.286, 95 %CI 0.108-0.464) influenced enhanced ETP in HF population.</p><p><strong>Conclusions: </strong>In diabetic patients with IHD, the diagnosis of HF is associated with more dense fibrin clots. HF patients with reduced versus preserved LVEF have shown enhanced thrombin generation and reduced clot permeability. Impairment of both LV systolic and vascular vasodilator function affected thrombin generation.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"19-26"},"PeriodicalIF":2.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subureteric injection in complex vesicoureteral reflux in pediatric patients: a retrospective observational study. 小儿复杂膀胱输尿管反流患者的腹腔注射:一项回顾性观察研究。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-17 DOI: 10.1016/j.advms.2026.01.001
Çiğdem Arslan Alıcı, Baran Tokar

Purpose: This study evaluated the effectiveness of subureteric injection (SUI) compared to ureteral reimplantation in treating vesicoureteral reflux (VUR) among children, focusing on whether SUI reduces the need for surgical interventions, especially in complex cases.

Method: We retrospectively analysed 132 children diagnosed with VUR. We divided the patients into two groups: Group 1 - only VUR cases (n = 65) and Group 2 - complex cases (n = 67). We diagnosed VUR and complex pathologies by voiding cystourethrography (VCUG) and cystoscopic examination. VUR was graded according to the International Reflux Study Committee classification system. SUI and intravesical ureteroneocystostomy (UNC) were used as surgical treatment methods.

Results: In Group 2, complex pathologies included duplex renal collecting systems (1.6 %), bladder diverticulum (11.4 %), bladder trabeculation (27.8 %), and posterior urethral valves (18 %). SUI was performed in 48.5 % of patients, with 22.7 % requiring reimplantation after SUI, while 28.8 % underwent direct reimplantation. Success rates of SUI (65.6 %) and reimplantation (70.6 %) were similar (p = 0.68), though lower in children aged 0-2 years with high-grade VUR (45 % for Grade 5) and renal scarring (48 %). Mean recurrence times were 8.4 ± 3.2 months for SUI and 9.1 ± 3.8 months for reimplantation.

Conclusions: The success of SUI and ureteral reimplantation was comparable in both simple and complex cases, suggesting SUI is a viable first-line option, particularly in patients older than 2 years with low-grade reflux. However, further studies are needed to confirm these findings.

目的:本研究评估了输尿管下注射(SUI)与输尿管再植治疗儿童膀胱输尿管反流(VUR)的有效性,重点关注SUI是否减少了手术干预的需要,特别是在复杂病例中。方法:对132例诊断为VUR的儿童进行回顾性分析。我们将患者分为两组:1组-单纯VUR病例(n=65)和2组-复杂病例(n=67)。我们通过排尿膀胱尿道造影(VCUG)和膀胱镜检查来诊断VUR和复杂的病理。根据国际反流研究委员会的分类系统对VUR进行分级。采用SUI和膀胱内输尿管膀胱造口术(UNC)作为手术治疗方法。结果:2组复杂病理包括双肾收集系统(1.6%)、膀胱憩室(11.4%)、膀胱小梁(27.8%)、后尿道瓣膜(18%)。48.5%的患者行SUI, 22.7%的患者在SUI后需要再植,28.8%的患者直接再植。SUI(65.6%)和再植(70.6%)的成功率相似(p=0.68),但0-2岁儿童高级别VUR(5级45%)和肾瘢痕(48%)的成功率较低。SUI的平均复发时间为8.4±3.2个月,再植的平均复发时间为9.1±3.8个月。结论:在简单和复杂的病例中,SUI和输尿管再植术的成功是相当的,这表明SUI是一个可行的一线选择,特别是对于年龄大于2岁的低级别反流患者。然而,需要进一步的研究来证实这些发现。
{"title":"Subureteric injection in complex vesicoureteral reflux in pediatric patients: a retrospective observational study.","authors":"Çiğdem Arslan Alıcı, Baran Tokar","doi":"10.1016/j.advms.2026.01.001","DOIUrl":"10.1016/j.advms.2026.01.001","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluated the effectiveness of subureteric injection (SUI) compared to ureteral reimplantation in treating vesicoureteral reflux (VUR) among children, focusing on whether SUI reduces the need for surgical interventions, especially in complex cases.</p><p><strong>Method: </strong>We retrospectively analysed 132 children diagnosed with VUR. We divided the patients into two groups: Group 1 - only VUR cases (n = 65) and Group 2 - complex cases (n = 67). We diagnosed VUR and complex pathologies by voiding cystourethrography (VCUG) and cystoscopic examination. VUR was graded according to the International Reflux Study Committee classification system. SUI and intravesical ureteroneocystostomy (UNC) were used as surgical treatment methods.</p><p><strong>Results: </strong>In Group 2, complex pathologies included duplex renal collecting systems (1.6 %), bladder diverticulum (11.4 %), bladder trabeculation (27.8 %), and posterior urethral valves (18 %). SUI was performed in 48.5 % of patients, with 22.7 % requiring reimplantation after SUI, while 28.8 % underwent direct reimplantation. Success rates of SUI (65.6 %) and reimplantation (70.6 %) were similar (p = 0.68), though lower in children aged 0-2 years with high-grade VUR (45 % for Grade 5) and renal scarring (48 %). Mean recurrence times were 8.4 ± 3.2 months for SUI and 9.1 ± 3.8 months for reimplantation.</p><p><strong>Conclusions: </strong>The success of SUI and ureteral reimplantation was comparable in both simple and complex cases, suggesting SUI is a viable first-line option, particularly in patients older than 2 years with low-grade reflux. However, further studies are needed to confirm these findings.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"40-45"},"PeriodicalIF":2.6,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the prognostic value of Wnt signaling pathways in non-small cell lung cancer patients 评价Wnt信号通路在非小细胞肺癌患者中的预后价值。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-23 DOI: 10.1016/j.advms.2025.12.002
Joanna Pancewicz , Paweł Golec , Anetta Sulewska , Radoslaw Charkiewicz , Wieslawa Niklinska , Piotr Michal Chodorowski , Miroslaw Kozlowski

Purpose

The Wnt/β-catenin signaling pathway is frequently deregulated in various malignancies, including non-small cell lung cancer (NSCLC). This study aimed to evaluate the expression levels of genes encoding ligands that are typically associated with the non-canonical Wnt/β-catenin pathways, specifically, WNT-4, WNT-5A, WNT-7A, WNT-11, and WNT-16 in NSCLC.

Materials and methods

The analysis was conducted on 80 matched pairs of tumor and adjacent non-cancerous lung tissues. Quantitative gene expression analysis was performed using real-time polymerase chain reaction (qPCR).

Results

The results revealed a consistent reduction in the expression of all investigated genes across NSCLC samples and their respective histological subtypes. Notably, elevated WNT-7A gene expression was observed between clinical early (IA) and intermediate IIA stages of NSCLC.

Conclusions

These findings suggest that alterations in the expression of non-canonical Wnt/β-catenin pathway ligands are integral to lung carcinogenesis and may play a critical role in the development of NSCLC. The observed changes in WNT-7A expression between IA and IIA stages of NSCLC further indicate its potential involvement in tumor progression.
目的:Wnt/β-catenin信号通路在包括非小细胞肺癌(NSCLC)在内的各种恶性肿瘤中经常失调。本研究旨在评估与非典型Wnt/β-catenin通路相关的配体编码基因在NSCLC中的表达水平,特别是Wnt -4、Wnt - 5a、Wnt - 7a、Wnt -11和Wnt -16。材料与方法:对80对配对的肿瘤及邻近非癌肺组织进行分析。采用实时聚合酶链反应(qPCR)进行定量基因表达分析。结果:结果显示所有研究基因在NSCLC样本及其各自的组织学亚型中的表达一致降低。值得注意的是,在NSCLC的临床早期(IA)和中期(IA)阶段,WNT-7A基因表达升高。结论:这些发现表明,非典型Wnt/β-catenin通路配体表达的改变是肺癌发生不可或缺的一部分,并可能在非小细胞肺癌的发展中发挥关键作用。观察到的WNT-7A在非小细胞肺癌IA期和IIA期的表达变化进一步表明其可能参与肿瘤进展。
{"title":"Evaluating the prognostic value of Wnt signaling pathways in non-small cell lung cancer patients","authors":"Joanna Pancewicz ,&nbsp;Paweł Golec ,&nbsp;Anetta Sulewska ,&nbsp;Radoslaw Charkiewicz ,&nbsp;Wieslawa Niklinska ,&nbsp;Piotr Michal Chodorowski ,&nbsp;Miroslaw Kozlowski","doi":"10.1016/j.advms.2025.12.002","DOIUrl":"10.1016/j.advms.2025.12.002","url":null,"abstract":"<div><h3>Purpose</h3><div>The Wnt/β-catenin signaling pathway is frequently deregulated in various malignancies, including non-small cell lung cancer (NSCLC). This study aimed to evaluate the expression levels of genes encoding ligands that are typically associated with the non-canonical Wnt/β-catenin pathways, specifically, <em>WNT-4</em>, <em>WNT-5A</em>, <em>WNT-7A</em>, <em>WNT-11</em>, and <em>WNT-16</em> in NSCLC.</div></div><div><h3>Materials and methods</h3><div>The analysis was conducted on 80 matched pairs of tumor and adjacent non-cancerous lung tissues. Quantitative gene expression analysis was performed using real-time polymerase chain reaction (qPCR).</div></div><div><h3>Results</h3><div>The results revealed a consistent reduction in the expression of all investigated genes across NSCLC samples and their respective histological subtypes. Notably, elevated <em>WNT-7A</em> gene expression was observed between clinical early (IA) and intermediate IIA stages of NSCLC.</div></div><div><h3>Conclusions</h3><div>These findings suggest that alterations in the expression of non-canonical Wnt/β-catenin pathway ligands are integral to lung carcinogenesis and may play a critical role in the development of NSCLC. The observed changes in <em>WNT-7A</em> expression between IA and IIA stages of NSCLC further indicate its potential involvement in tumor progression.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Pages 10-18"},"PeriodicalIF":2.6,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145832099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Investigation of the effects of umbilical cord and adipose-derived mesenchymal stem cells on endoplasmic reticulum stress in cadmium-induced rat kidney” [Adv. Med. Sci. (2025 Oct) 70 (2) 284-290] 《脐带和脂肪来源的间充质干细胞对镉诱导大鼠肾脏内质网应激影响的研究》的勘误表。(2025 Oct) 70(2) 284-290。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-16 DOI: 10.1016/j.advms.2025.12.001
Bahar Kartal , Uygar Saçik , Güven Erbil
{"title":"Corrigendum to “Investigation of the effects of umbilical cord and adipose-derived mesenchymal stem cells on endoplasmic reticulum stress in cadmium-induced rat kidney” [Adv. Med. Sci. (2025 Oct) 70 (2) 284-290]","authors":"Bahar Kartal ,&nbsp;Uygar Saçik ,&nbsp;Güven Erbil","doi":"10.1016/j.advms.2025.12.001","DOIUrl":"10.1016/j.advms.2025.12.001","url":null,"abstract":"","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Page 9"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145779815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study 间皮素作为子宫内膜异位症的诊断生物标志物:一项横断面研究。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-11-28 DOI: 10.1016/j.advms.2025.11.002
Kamil Kiecka , Aleksandra Zygula , Anna Sankiewicz , Mariusz Kuzmicki , Slawomir Lawicki , Michal Ciebiera , Tadeusz Issat , Jan Blaszczyk , Krzysztof Cendrowski , Ewa Gorodkiewicz , Piotr Laudanski

Purpose

Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid (PF) and plasma.

Materials/methods

In a multicenter cross-sectional study, MSLN concentrations were measured using Surface Plasmon Resonance imaging (SPRi) biosensors in samples from women undergoing laparoscopy for pelvic pain or infertility.

Results

Significantly higher MSLN levels were observed in the PF of patients with endometriosis compared to controls (mean concentrations: 10.24 vs. 9.39 ​ng/mL, p ​= ​0.038). The elevation was particularly notable in patients with stage I and II endometriosis compared to the control group (mean concentrations: 10.83 vs. 9.39 ​ng/mL, p ​= ​0.049). No significant differences were observed in plasma.

Conclusions

Mesothelin in PF may be considered as a potential biomarker for endometriosis, especially in its early stages. Further studies are needed to confirm its diagnostic value.
目的:子宫内膜异位症是一种常见的妇科疾病,通常需要侵入性手术来诊断。本研究旨在通过分析腹膜液(PF)和血浆中间皮素(MSLN)的水平来评估其作为一种潜在的非侵入性生物标志物的价值。材料/方法:在一项多中心横断面研究中,使用表面等离子体共振成像(SPRi)生物传感器测量盆腔疼痛或不孕症妇女腹腔镜检查样本中的MSLN浓度。结果:与对照组相比,子宫内膜异位症患者PF中MSLN水平显著升高(平均浓度:10.24 vs. 9.39 ng/mL, p = 0.038)。与对照组相比,I期和II期子宫内膜异位症患者的升高尤为显著(平均浓度:10.83 vs. 9.39 ng/mL, p = 0.049)。血浆中未见明显差异。结论:间皮素可能被认为是子宫内膜异位症的潜在生物标志物,特别是在其早期阶段。其诊断价值有待进一步研究证实。
{"title":"Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study","authors":"Kamil Kiecka ,&nbsp;Aleksandra Zygula ,&nbsp;Anna Sankiewicz ,&nbsp;Mariusz Kuzmicki ,&nbsp;Slawomir Lawicki ,&nbsp;Michal Ciebiera ,&nbsp;Tadeusz Issat ,&nbsp;Jan Blaszczyk ,&nbsp;Krzysztof Cendrowski ,&nbsp;Ewa Gorodkiewicz ,&nbsp;Piotr Laudanski","doi":"10.1016/j.advms.2025.11.002","DOIUrl":"10.1016/j.advms.2025.11.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid (PF) and plasma.</div></div><div><h3>Materials/methods</h3><div>In a multicenter cross-sectional study, MSLN concentrations were measured using Surface Plasmon Resonance imaging (SPRi) biosensors in samples from women undergoing laparoscopy for pelvic pain or infertility.</div></div><div><h3>Results</h3><div>Significantly higher MSLN levels were observed in the PF of patients with endometriosis compared to controls (mean concentrations: 10.24 vs. 9.39 ​ng/mL, p ​= ​0.038). The elevation was particularly notable in patients with stage I and II endometriosis compared to the control group (mean concentrations: 10.83 vs. 9.39 ​ng/mL, p ​= ​0.049). No significant differences were observed in plasma.</div></div><div><h3>Conclusions</h3><div>Mesothelin in PF may be considered as a potential biomarker for endometriosis, especially in its early stages. Further studies are needed to confirm its diagnostic value.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Pages 1-8"},"PeriodicalIF":2.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145646923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and clinical associations of antinuclear antibodies (ANA) in spondyloarthropathies 抗核抗体(ANA)在脊椎关节病中的患病率及临床相关性。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 DOI: 10.1016/j.advms.2025.09.005
Adrianna Błahuszewska-Omyła , Emilia Frąckiel , Marek Bielecki , Ewa Gińdzieńska- Sieśkiewicz , Natalia Szymańska , Otylia Kowal-Bielecka

Purpose

Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.

Patients and methods

The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n ​= ​52), psoriatic arthritis (n ​= ​34), and non-radiographic SpA (n ​= ​31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.

Results

ANA were found in 46 ​% of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 ​%) was found in women with non-radiographic spondyloarthropathy and the lowest (38 ​%) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.

Conclusion

The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.
目的:脊椎关节病(SpA)是一种广泛而多样的疾病,具有高度可变的临床表现。由于这种广泛的症状及其与其他疾病实体的频繁重叠,SpA提出了许多诊断和治疗挑战。此外,SpA的发病机制尚不清楚。虽然目前流行的假设认为是一种自身炎症机制,但不排除自身免疫过程的参与。为了探索这种可能性,本研究旨在评估SpA患者中抗核抗体(ANA)的存在及其临床相关性。患者和方法:分析包括117例不同形式SpA的连续患者,即强直性脊柱炎(n = 52),银屑病关节炎(n = 34)和非影像学SpA (n = 31)。他们接受了临床评估,并从每个人身上收集血清样本进行间接免疫荧光检测。结果:46%的SpA患者存在ANA。ANA与特定SpA的诊断或临床症状之间没有统计学意义的关联。有趣的是,ANA的最高患病率(63%)出现在女性非影像学脊柱关节病患者中,最低患病率(38%)出现在男性强直性脊柱炎患者中,但差异没有达到统计学意义。结论:我们的研究结果提示,ANA在SpA患者中较为常见,尤其是在早期非影像学的SpA患者中,这可能具有临床意义。然而,需要进一步的研究,涉及更大的人群,来阐明ANA在SpA患者中存在的意义。
{"title":"Prevalence and clinical associations of antinuclear antibodies (ANA) in spondyloarthropathies","authors":"Adrianna Błahuszewska-Omyła ,&nbsp;Emilia Frąckiel ,&nbsp;Marek Bielecki ,&nbsp;Ewa Gińdzieńska- Sieśkiewicz ,&nbsp;Natalia Szymańska ,&nbsp;Otylia Kowal-Bielecka","doi":"10.1016/j.advms.2025.09.005","DOIUrl":"10.1016/j.advms.2025.09.005","url":null,"abstract":"<div><h3>Purpose</h3><div>Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.</div></div><div><h3>Patients and methods</h3><div>The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n ​= ​52), psoriatic arthritis (n ​= ​34), and non-radiographic SpA (n ​= ​31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.</div></div><div><h3>Results</h3><div>ANA were found in 46 ​% of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 ​%) was found in women with non-radiographic spondyloarthropathy and the lowest (38 ​%) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.</div></div><div><h3>Conclusion</h3><div>The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 377-381"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145090759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The transition from intravenous to subcutaneous infliximab in a cohort of patients with inflammatory bowel disease: results of the INESTIMABLE retrospective observational study 炎症性肠病患者从静脉注射到皮下注射英夫利昔单抗的转变:INESTIMABLE回顾性观察性研究的结果
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 DOI: 10.1016/j.advms.2025.10.001
Alessia Todeschini , Andrea Geccherle , Paola Signoretto , Nicoletta Colaci , Federica Mellone , Nicoletta De Santis , Massimo Guerriero , Giuliano Barugola , Angela Variola

Purpose

This study aimed to present real-world data regarding the treatment of inflammatory bowel disease (IBD) with the subcutaneous (SC) formulation of the tumor necrosis factor inhibitor, infliximab.

Methods

Adult IBD patients who switched from intravenous (IV) infliximab to SC infliximab were recruited for this study. Data on the efficacy of maintaining long-term remission, persistence in therapy and the safety profile were obtained from medical records and physician assessments conducted during routine clinical practice. Data on adherence to treatment schedules and patient satisfaction were collected through an ad hoc questionnaire. The duration of the follow-up was 12 months.

Results

The treatment with SC infliximab was generally well-tolerated, with a persistence rate of 86.7 ​% at 12 months and adherence to the treatment schedule of 86.4 ​%. Patients reported a favorable experience with self-injections. Mild, self-limiting adverse events were observed, and inflammatory biomarkers decreased over time, suggesting maintenance of remission in most patients.

Conclusions

The findings suggest that SC infliximab may be a viable option for IBD patients in remission who are eligible for switching, offering a self-administered alternative to IV therapy.
目的:本研究旨在提供有关肿瘤坏死因子抑制剂英夫利昔单抗皮下(SC)制剂治疗炎症性肠病(IBD)的真实数据。方法:本研究招募了从静脉注射(IV)英夫利昔单抗转为SC英夫利昔单抗的成年IBD患者。关于维持长期缓解的有效性、持续治疗和安全性的数据来自常规临床实践期间进行的医疗记录和医生评估。对治疗计划的依从性和患者满意度的数据通过特别问卷收集。随访时间为12个月。结果:SC英夫利昔单抗治疗总体耐受良好,12个月的持续率为86.7%,治疗方案的依从性为86.4%。患者报告了自我注射的良好体验。观察到轻微的自限性不良事件,炎症生物标志物随着时间的推移而下降,表明大多数患者维持缓解。结论:研究结果表明,SC英夫利昔单抗可能是IBD缓解期患者的可行选择,他们有资格转换,提供了一种自我给药的替代静脉注射治疗。
{"title":"The transition from intravenous to subcutaneous infliximab in a cohort of patients with inflammatory bowel disease: results of the INESTIMABLE retrospective observational study","authors":"Alessia Todeschini ,&nbsp;Andrea Geccherle ,&nbsp;Paola Signoretto ,&nbsp;Nicoletta Colaci ,&nbsp;Federica Mellone ,&nbsp;Nicoletta De Santis ,&nbsp;Massimo Guerriero ,&nbsp;Giuliano Barugola ,&nbsp;Angela Variola","doi":"10.1016/j.advms.2025.10.001","DOIUrl":"10.1016/j.advms.2025.10.001","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to present real-world data regarding the treatment of inflammatory bowel disease (IBD) with the subcutaneous (SC) formulation of the tumor necrosis factor inhibitor, infliximab.</div></div><div><h3>Methods</h3><div>Adult IBD patients who switched from intravenous (IV) infliximab to SC infliximab were recruited for this study. Data on the efficacy of maintaining long-term remission, persistence in therapy and the safety profile were obtained from medical records and physician assessments conducted during routine clinical practice. Data on adherence to treatment schedules and patient satisfaction were collected through an <em>ad hoc</em> questionnaire. The duration of the follow-up was 12 months.</div></div><div><h3>Results</h3><div>The treatment with SC infliximab was generally well-tolerated, with a persistence rate of 86.7 ​% at 12 months and adherence to the treatment schedule of 86.4 ​%. Patients reported a favorable experience with self-injections. Mild, self-limiting adverse events were observed, and inflammatory biomarkers decreased over time, suggesting maintenance of remission in most patients.</div></div><div><h3>Conclusions</h3><div>The findings suggest that SC infliximab may be a viable option for IBD patients in remission who are eligible for switching, offering a self-administered alternative to IV therapy.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 392-400"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145273320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use 增强临床潜力:脂肪组织来源的间充质干细胞/基质细胞用于治疗的质量评估
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 DOI: 10.1016/j.advms.2025.10.002
Monika Rytel , Magdalena Chodkowska-Michalowska , Dorota Sulejczak , Natalia Krześniak , Marzena Zychowicz , Anna Sarnowska

Purpose

Despite ongoing debate surrounding mesenchymal stem/stromal cells (MSCs), the number of clinical trials involving MSCs has continued to increase due to their strong therapeutic potential. These cells exhibit immunosuppressive and neuroprotective properties, making them a promising approach for treating neurodegenerative diseases. Given the growing interest in stem cell-based therapies, it is essential to establish specific protocols for manufacturing adipose-derived MSCs. This study outlines the process of obtaining an ATMP cell product from ASCs, evaluating cell quality, isolation efficiency, and optimal conditions for cryopreservation, preparation, and transport.

Materials and methods

Cells were isolated from fresh, cryopreserved, and 4°C-stored adipose tissue to evaluate how different storage conditions affect cell quality. In addition, cell viability in different transport solutions over time was examined. To evaluate the therapeutic potential of ASCs, cells were cultured in cerebrospinal fluid (CSF) and neural gene and protein expression, as well as the secretome profile, were analysed.

Results

Our findings show that isolating ASCs immediately after liposuction yields the highest viable cell count. Adipose tissue can be stored at 4 ​°C for up to 48 ​h without affecting cell population doubling time, but cryopreservation negatively impacts ASCs’ clonogenicity. For optimal long-term preservation, a medium with 5 ​% platelet lysate and 10 ​% DMSO is recommended. Additionally, we found that 0.9 ​% NaCl is the best transport medium for maintaining cell viability. CSF exposure induced neural markers (NG2, A2B5, Nestin, β-III-tubulin, S-100-β) and morphological changes, suggesting neural-like differentiation.

Conclusions

These findings contribute to the development of protocols for MSC therapy in neurodegenerative diseases.
尽管围绕间充质干细胞(MSCs)的争论仍在继续,但由于其强大的治疗潜力,涉及MSCs的临床试验数量不断增加。这些细胞表现出免疫抑制和神经保护特性,使它们成为治疗神经退行性疾病的有希望的方法。鉴于对干细胞疗法的兴趣日益增长,建立制造脂肪来源的间充质干细胞的特定方案至关重要。本研究概述了从ASCs中获得ATMP细胞产品的过程,评估了细胞质量、分离效率以及冷冻保存、制备和运输的最佳条件。材料和方法从新鲜、低温保存和4°c储存的脂肪组织中分离细胞,以评估不同储存条件对细胞质量的影响。此外,随着时间的推移,细胞活力在不同的运输溶液进行了检查。为了评估ASCs的治疗潜力,在脑脊液(CSF)中培养细胞,分析神经基因和蛋白质表达以及分泌组谱。结果吸脂后立即分离ASCs可获得最高的活细胞计数。脂肪组织可在4℃下保存48小时,不影响细胞群体倍增时间,但低温保存会对ASCs的克隆原性产生负面影响。为了获得最佳的长期保存,推荐使用含有5%血小板裂解液和10% DMSO的培养基。此外,我们发现0.9% NaCl是维持细胞活力的最佳运输培养基。脑脊液暴露诱导神经标记物(NG2、A2B5、Nestin、β- iii -微管蛋白、S-100-β)和形态学改变,提示神经样分化。结论这些发现有助于MSC治疗神经退行性疾病方案的发展。
{"title":"Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use","authors":"Monika Rytel ,&nbsp;Magdalena Chodkowska-Michalowska ,&nbsp;Dorota Sulejczak ,&nbsp;Natalia Krześniak ,&nbsp;Marzena Zychowicz ,&nbsp;Anna Sarnowska","doi":"10.1016/j.advms.2025.10.002","DOIUrl":"10.1016/j.advms.2025.10.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Despite ongoing debate surrounding mesenchymal stem/stromal cells (MSCs), the number of clinical trials involving MSCs has continued to increase due to their strong therapeutic potential. These cells exhibit immunosuppressive and neuroprotective properties, making them a promising approach for treating neurodegenerative diseases. Given the growing interest in stem cell-based therapies, it is essential to establish specific protocols for manufacturing adipose-derived MSCs. This study outlines the process of obtaining an ATMP cell product from ASCs, evaluating cell quality, isolation efficiency, and optimal conditions for cryopreservation, preparation, and transport.</div></div><div><h3>Materials and methods</h3><div>Cells were isolated from fresh, cryopreserved, and 4°C-stored adipose tissue to evaluate how different storage conditions affect cell quality. In addition, cell viability in different transport solutions over time was examined. To evaluate the therapeutic potential of ASCs, cells were cultured in cerebrospinal fluid (CSF) and neural gene and protein expression, as well as the secretome profile, were analysed.</div></div><div><h3>Results</h3><div>Our findings show that isolating ASCs immediately after liposuction yields the highest viable cell count. Adipose tissue can be stored at 4 ​°C for up to 48 ​h without affecting cell population doubling time, but cryopreservation negatively impacts ASCs’ clonogenicity. For optimal long-term preservation, a medium with 5 ​% platelet lysate and 10 ​% DMSO is recommended. Additionally, we found that 0.9 ​% NaCl is the best transport medium for maintaining cell viability. CSF exposure induced neural markers (NG2, A2B5, Nestin, β-III-tubulin, S-100-β) and morphological changes, suggesting neural-like differentiation.</div></div><div><h3>Conclusions</h3><div>These findings contribute to the development of protocols for MSC therapy in neurodegenerative diseases.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 408-424"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145473604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: “Structured team response and sex-based mortality gaps in acute pulmonary embolism: Conflicting evidence and future directions” 致编辑的信:“急性肺栓塞的结构化团队反应和基于性别的死亡率差距:相互矛盾的证据和未来方向”。
IF 2.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 DOI: 10.1016/j.advms.2025.10.004
Artur Dziewierz , Barbara Zdzierak , Roman M. Wojdyła
{"title":"Letter to the editor: “Structured team response and sex-based mortality gaps in acute pulmonary embolism: Conflicting evidence and future directions”","authors":"Artur Dziewierz ,&nbsp;Barbara Zdzierak ,&nbsp;Roman M. Wojdyła","doi":"10.1016/j.advms.2025.10.004","DOIUrl":"10.1016/j.advms.2025.10.004","url":null,"abstract":"","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 425-426"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in medical sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1